Mediators of inflammation and the inflammatory process

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 3 SUPPL., 1999, Pages

  White, Martha ^a,b  

^a Institute for Asthma and Allergy   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; HISTAMINE; KININ DERIVATIVE; LEUKOTRIENE; PROSTAGLANDIN; THROMBOCYTE ACTIVATING FACTOR;

ALLERGY; HUMAN; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MAST CELL DEGRANULATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

HUMANS; HYPERSENSITIVITY; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 0033016595     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70215-0     Document Type: Article

References (42)

1. Ash ASF, Schild HO. Receptors mediating some actions of histamine. Br J Pharmac Chemother 1966;27:427-37.
2. Pearce FL. Biological effects of histamine: an overview. Agents Actions 1991;33:4-7.
3. Metcalfe DD, Kaliner M, Donlon MA. The mast cell. CRC Crit Rev Immunol 1981;3:23-74.
4. Uvnas B, Aborg CH, Bergendoff A. Storage of mast cells. Evidence for an ionic binding of histamine to protein carboxyls in the granule heparin protein complex. Acta Physiol Scand 1970;336(Suppl):3-26.
5. 1-agonist stimulated breakdown on inositol phospholipids. Oxford: Pergammon; 1985. p. 27-38.
6. Uvnas B. Release process in mast cells and their activation by injury. Ann NY Acad Sci 1964;116:880-90.
7. Dvorak AM. New aspects of mast cell biology. Int Arch Allergy Immunol 1997;114:1-9.
8. Pearce FL. The mast cell. Immunol Allergy Clin North Am 1990;10:251-62.
9. Bhattacharyya SP, Drucker I, Reshef T, Kirshenbaum AS, Metcalfe DD, Mekori YA. Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 1998;63:337-41.
10. Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis 1991;143:S91-5.
11. Rihoux JP, Masliah J, Bereziat G, Konig W. G proteins as biological targets for anti-allergic drugs? Int Arch Allergy Immunol 1997;113:339-41.
12. Ho PC, Orange RP. Indirect evidence of phospholipase A activation in purified rat mast cells during reverse anaphylactic challenge. FASEB Proc 1978;37:1667.
13. Kennerly DA, Sullivan TJ, Sylvester P, Parker CW. Diacylglycerol metabolism in mast cells. A potential role in membrane fusion and arachidonic acid release. J Exp Med 1979;150:1039-44.
14. Soberman RJ, Harper TW, Betteridge D, Lewis RA, Austen KF. Characterization and separation of the arachidonic acid 5-lipoxygenase and linoleic acid Ω-6 lipoxygenase (arachidonic acid 15-lipoxygenase) of human polymorphonuclear leukocytes. J Biol Chem 1985;260:4508-15.
15. Rouzer CA, Matsumoto T, Samuelsson B. Single protein from human leukocytes possesses 5-lipoxygenase and leukotriene A4 synthase activities. Proc Natl Acad Sci USA 1986;83:857-61.
16. Borgeat P, Samuelsson B. Transformation of arachidonic acid by rabbit polymorphonuclear leukocytes. J Biol Chem 1979;254:2643-6.
17. Corey EJ, Marfat A, Goto G, Brion F. Leukotriene B. Total synthesis and assignment of stereochemistry. J Am Chem Soc 1980b;102:7984-5.
18. Corey EJ, Clark DA, Goto G, Marfat A, Mioskowski C, Samuelsson B, et al. Stereospecific total synthesis of a "slow reacting substance" of anaphylaxis, leukotriene C-1. J Am Chem Soc 1980a;102:1436-9.
19. Lewis RA, Holgate ST, Roberts LJ II, Oates JA, Austen KF. Preferential generation of prostaglandin D2 by rat and human mast cells. In: Becker EL, Simon AS, Austen KF, editors. Biochemistry of the acute allergic reactions. New York: Liss; 1981. p. 239-54.
20. Schwartz L, Huff T. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis(Mo): Mosby; 1993. p. 150.
21. Schwartz LB, Austen KF. Structure and function of the chemical mediators of mast cells. Prog Allergy 1984;34:271-321.
22. Hamberg M, Svensson J, Wakaboyashi T, Samuelsson B. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci USA 1974;71:345-9.
23. Proud D, Kaplan AP. Kinin formation: mechanisms and role in inflammatory disorders. Ann Rev Immunol 1988;6:49-83.
24. Bhoola KD, Collier HOJ, Schachter M, Shorley PG. Actions of some peptides on bronchial muscle. Br J Pharmacol 1962;19:190-7.
25. Keele CA. Clinical and pathological aspects of kinins in man. Proc R Soc Biol 1969;173:361-9.
26. Weiss AS, Gallin JI, Kaplan AP. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest 1974;53:622-33.
27. Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, et al. Williams Trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 1975;56:1650-62.
28. Nustad K, Orstavik TB, Gautvik KM, Pierce JV. Glandular kallikreins. Gen Pharmacol 1978;9:1-9.
29. Proud D, Macglashan DW Jr, Newball HH, Schulman ES, Lichenstein LM. Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am Rev Respir Dis 1985;132:405-8.
30. Newball HH, Berninger RW, Talamo RC, Lichtenstein LM. Anaphylactic release of a basophil kallikrein-like activity: purification and characterization. J Clin Invest 1979;64:457-65.
31. Baraniuk JN, Lundgren JD, Mizoguchi M, Peden D, Gawin A, Merida M, et al. Bradykinin and respiratory mucous membranes. Analysis of bradykinin binding site distribution and secretory responses in vitro and in vivo. Am Rev Respir Dis 1990;141:706-14.
32. Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of azelastine on the early allergic response. Clin Exp Allergy 1992;22:289-95.
33. Barbara IF, Zvaifler NJ. Antigen induced histamine release from platelets of rabbits producing homologous PCA antibody. Proc Soc Exp Biol Med 1966;122:1245-7.
34. Barnes PJ. Pathophysiology of allergic inflammation. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed. St Louis(Mo): Mosby; 1993. p. 255-6.
35. Bradding P, Holgate ST. The mast cell as a source of cytokines in asthma. Ann NY Acad Sci 1996;796:272-81.
36. Bradding P, Feather IH, Wilson S, Holgate ST, Howarth PH. Cytokine immunoreactivity in seasonal rhinitis: regulation by a topical corticosteroid. Am J Respir Crit Care Med 1995;151:1900-6.
37. Benson M, Strannegard IL, Wennergren G, Strannegard O. Cytokines in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol 1997;8:143-9.
38. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
39. Alam R, Lett-Brown MA, Forsythe PA, Anderson-Walters DJ, Kenamore C, Kormos C, et al. Monocyte chemotactic and activating factor (MCAF) is a potent histamine-releasing factor for basophils. J Clin Invest 1992;89:723-8.
40. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994;79:751-6.
41. Sim TC, Reece LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995;152:927-33.
42. Fish JE, Kemp JP, Lockey RF, Glass M, Hanby LA, Bonucelli CM. Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. Clin Ther 1997;19:675-90.